Author Archives: Rebecca Vesely

Rebecca Vesely

About Rebecca Vesely

Rebecca Vesely is AHCJ's topic leader on health information technology and a freelance writer. She has written about health, science and medicine for AFP, the Bay Area News Group, Modern Healthcare, Wired, Scientific American online and many other news outlets.

FDA issues another reminder about the risks of connected medical devices to hacking

In recent years, as medical devices have become more connected, cybersecurity experts have sounded the alarm on their vulnerabilities.

A panel at Health Journalism 2018 covered the topic, with experts encouraging reporters to ask their local hospitals about plans to safeguard medical devices from cyber threats. Continue reading

Survey: People trust their smartphones more than hospitals with their personal data

Photo: HP Samsung Terbaru via Flickr

Nearly half of consumers believe their personal health information is more secure on their personal electronic devices – smartphones, laptops and tablets – than it is on their health care providers’ computer systems.

This high level of mistrust in health entities’ handling of personal data is among the findings of a recent survey of 1,000 consumers by the cybersecurity firm Morphisec. Benjamin Harris of HealthcareITNews reported on the survey. Continue reading

FCC will vote next month on a $100 million telehealth initiative

The Federal Communications Commission will vote on July 10 to advance a $100 million telehealth initiative to boost funding for care programs that serve rural low-income Americans at home, FCC Commissioner Brendan Carr said this week at an event in rural Virginia.

The Connected Care Pilot Program would fund eligible health providers so they can obtain the broadband needed to provide remote patient monitoring and connected technologies to patients, Carr said. The three-year pilot will track costs, savings and outcomes, he said. Continue reading

Panelists break down the realities of precision medicine and immunotherapy

Otis Brawley, M.D., and Matthew Ong, of The Cancer Letter, were on the panel “How precision medicine and immunotherapy are redefining the approach to cancer treatment.”

Are precision medicine and immunotherapy overhyped as cancer treatments, or do they hold such tremendous promise that we are only just starting to see the potential?

That was the overarching question for the panel discussion at Health Journalism 2019, “How precision medicine and immunotherapy are redefining cancer treatment.”

“I do worry that precision medicine and immunotherapy are overhyped,” said Otis W. Brawley, M.D., Bloomberg distinguished professor of oncology and epidemiology at the Bloomberg School of Public Health and John Hopkins Kimmel Cancer Center. Brawley also was the Thursday night speaker at Health Journalism 2019. Continue reading

Opioid epidemic, rural health spurring wider adoption of telehealth, panel says

In just the past few years, telehealth has gained some momentum, in part spurred by the opioid epidemic and an aging rural population.

Medicare, in particular, has loosened some of its requirements around telehealth reimbursement starting in 2017, said Mei W. Kwong, executive director for the Center for Connected Health Policy and National Telehealth Policy Resource Center, which tracks state and federal telehealth legislation. Continue reading

Think of artificial intelligence as city planning, not building construction, panel says

Artificial intelligence (AI) is one of the hottest topics in health care and it has the potential to transform care delivery in hospitals, clinics and in the home.

The Health Journalism 2019 panel “Hope vs. Hype: Reporting on AI” offered some examples where AI is being applied to medical care today. It also tapped the brakes on some of the hype. Continue reading